Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 | Dec-31-07 | Dec-31-06 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Sales Revenue, End Market | 892.9 | 829.2 | 896.1 | 878.7 | | | | |
| United States and other | 500.2 | 764.3 | 896.1 | 878.7 | | | | |
| Costa Rica | 32.1 | 27.3 | 31.3 | 25.9 | 23.3 | | | 17.5 |
| United States | | | | | 654.3 | | | 401.8 |
| Total revenues | 892.9 | 829.2 | 896.1 | 878.7 | 654.3 | 573.4 | 475.8 | 401.8 |
| Revenue growth [+] | 7.7% | -7.5% | 2.0% | 34.3% | 14.1% | 20.5% | 18.4% | 36.3% |
| Sales Revenue, End Market | 7.7% | -7.5% | 2.0% | | | | | |
| United States and other | -34.6% | -14.7% | 2.0% | | | | | |
| Costa Rica | 17.7% | -12.8% | 20.6% | 11.6% | | | | |
| Cost of goods sold | 635.2 | 591.6 | 574.2 | 527.9 | 445.7 | 387.5 | 324.5 | 277.9 |
| Gross profit | 257.7 | 237.6 | 321.9 | 350.8 | 208.6 | 186.0 | 151.3 | 123.9 |
| Gross margin | 28.9% | 28.7% | 35.9% | 39.9% | 31.9% | 32.4% | 31.8% | 30.8% |
| Selling, general and administrative | 108.4 | 106.6 | 96.8 | 96.1 | 78.4 | 72.6 | 60.9 | 55.2 |
| Research and development | 190.0 | 160.5 | 146.9 | 129.2 | 109.4 | 91.5 | 65.4 | 50.3 |
| Other operating expenses | | | | | 1.2 | 0.5 | 1.2 | |
| EBITDA [+] | 65.8 | 67.0 | 144.3 | 180.2 | 66.5 | | | 49.9 |
| EBITDA growth | -1.8% | -53.5% | -19.9% | 170.8% | 211.0% | -10.2% | -52.3% | 92.4% |
| EBITDA margin | 7.4% | 8.1% | 16.1% | 20.5% | 10.2% | 3.7% | 5.0% | 12.4% |
| Depreciation | 99.8 | 90.0 | 59.9 | 48.8 | 41.5 | | | 31.5 |
| EBITA | -33.9 | -23.0 | 84.4 | 131.4 | 25.0 | 21.4 | 23.8 | 18.4 |
| EBITA margin | -3.8% | -2.8% | 9.4% | 15.0% | 3.8% | 3.7% | 5.0% | 4.6% |
| Amortization of intangibles | 6.8 | 6.5 | 6.1 | 5.9 | 5.4 | | | |
| EBIT [+] | -40.7 | -29.5 | 78.3 | 125.5 | 19.6 | 21.4 | 23.8 | 18.4 |
| EBIT growth | 37.8% | -137.7% | -37.6% | 541.1% | -8.5% | -10.2% | 29.3% | -306.3% |
| EBIT margin | -4.6% | -3.6% | 8.7% | 14.3% | 3.0% | 3.7% | 5.0% | 4.6% |
| Non-recurring items [+] | | 7.5 | 19.2 | 9.4 | 3.0 | 35.3 | 7.6 | -0.5 |
| Asset impairment | | | | | | 33.9 | | |
| Legal settlement | | 7.5 | 19.2 | 9.4 | 3.0 | | | |
| Interest income, net [+] | -4.4 | -1.9 | -1.3 | -0.7 | -0.2 | 2.8 | 1.5 | 5.7 |
| Interest expense | 4.5 | 2.1 | 1.6 | 1.1 | 1.0 | | | 9.9 |
| Interest income | 0.1 | 0.2 | 0.3 | 0.4 | 0.8 | 2.8 | 1.5 | 15.6 |
| Other income (expense), net [+] | 0.0 | 7.1 | 1.2 | 1.1 | 0.2 | 11.1 | -17.7 | -0.1 |
| Gain (loss) on foreign currency transactions | | | | | -0.2 | | | |
| Pre-tax income | -45.1 | -31.9 | 59.0 | 116.5 | 16.7 | 0.0 | 0.0 | 24.5 |
| Income taxes | -7.1 | -5.7 | 10.8 | -74.3 | 0.4 | 0.0 | 0.0 | 2.8 |
| Tax rate | 15.7% | 17.9% | 18.4% | | 2.4% | | | 11.4% |
| Net income | -38.0 | -26.2 | 48.2 | 190.8 | 16.2 | 0.0 | 0.0 | 21.8 |
| Net margin | -4.3% | -3.2% | 5.4% | 21.7% | 2.5% | 0.0% | 0.0% | 5.4% |
| |
| Basic EPS [+] | ($0.24) | ($0.16) | $0.29 | $1.22 | $0.11 | $0.00 | $0.00 | $0.16 |
| Growth | 49.8% | -154.3% | -76.1% | 1028.7% | | | -100.0% | -72675271.8% |
| Diluted EPS [+] | ($0.24) | ($0.16) | $0.28 | $1.17 | $0.11 | $0.00 | $0.00 | $0.15 |
| Growth | 49.8% | -157.0% | -76.1% | 994.6% | | | -100.0% | -71669990.9% |
| |
| Shares outstanding (basic) [+] | 159.3 | 164.4 | 164.3 | 155.9 | 149.8 | 144.5 | 140.2 | 139.2 |
| Growth | -3.1% | 0.1% | 5.4% | 4.1% | 3.6% | 3.1% | 0.7% | -0.2% |
| Shares outstanding (diluted) [+] | 159.3 | 164.4 | 172.5 | 163.5 | 152.3 | 144.5 | 142.5 | 141.2 |
| Growth | -3.1% | -4.7% | 5.5% | 7.3% | 5.4% | 1.4% | 0.9% | 1.2% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|